ClinicalTrials.Veeva

Menu

Testing a Multilevel, Culturally Appropriate Lifestyle Intervention For Hispanic Patients With Metabolic-dysfunction Associated Steatotic Liver Disease

The University of Texas System (UT) logo

The University of Texas System (UT)

Status

Not yet enrolling

Conditions

Metabolic-dysfunction Associated Liver Disease (MASLD)

Treatments

Behavioral: Usual Care
Behavioral: Healthy Liver/Hígado Sano program

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT07199491
HSC-SPH-25-0539
K01MD019149 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The purpose of this study is to understand if a behavioral lifestyle intervention called the Healthy Liver/Hígado Sano program can help Hispanic/Latino patients with metabolic dysfunction associated steatotic liver disease (MASLD), also known as non-alcoholic fatty liver disease (NAFLD), lose weight and improve their liver health

Enrollment

64 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Self-reported Hispanic/Latino
  • Have been diagnosed with MASLD
  • Able to speak English or Spanish
  • Have access to internet, either on their phone, at home or at some other location convenient to the participant
  • Have a family member willing to attend all sessions

Exclusion criteria

  • Does not have a working telephone number

Trial design

Primary purpose

Prevention

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

64 participants in 2 patient groups

Healthy Liver/Hígado Sano program
Experimental group
Treatment:
Behavioral: Healthy Liver/Hígado Sano program
Usual Care
Active Comparator group
Treatment:
Behavioral: Usual Care

Trial contacts and locations

1

Loading...

Central trial contact

Natalia Heredia

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems